Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 27.34
(-1.12%)
CNY 27.34
(-1.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 308.14 Million CNY | -38.23% |
| 2022 | 498.88 Million CNY | 42.65% |
| 2021 | 349.73 Million CNY | -19.31% |
| 2020 | 433.43 Million CNY | 4.11% |
| 2019 | 416.34 Million CNY | -2.49% |
| 2018 | 426.97 Million CNY | 0.03% |
| 2017 | 426.86 Million CNY | 25.47% |
| 2016 | 340.21 Million CNY | 245.66% |
| 2015 | 98.42 Million CNY | 15.03% |
| 2014 | 85.56 Million CNY | -70.49% |
| 2013 | 289.98 Million CNY | -30.25% |
| 2012 | 415.74 Million CNY | 36.28% |
| 2011 | 305.06 Million CNY | 308.33% |
| 2010 | 74.71 Million CNY | -2.18% |
| 2009 | 76.37 Million CNY | -19.42% |
| 2008 | 94.78 Million CNY | 27.92% |
| 2007 | 74.09 Million CNY | 2.79% |
| 2006 | 72.09 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 872.27 Million CNY | 168.68% |
| 2024 Q1 | 416.25 Million CNY | 35.09% |
| 2024 Q2 | 324.65 Million CNY | -22.01% |
| 2023 Q1 | 319.39 Million CNY | -35.98% |
| 2023 FY | 308.14 Million CNY | -38.23% |
| 2023 Q4 | 308.14 Million CNY | -16.24% |
| 2023 Q3 | 367.89 Million CNY | 7.01% |
| 2023 Q2 | 343.8 Million CNY | 7.64% |
| 2022 Q1 | 330.66 Million CNY | -5.45% |
| 2022 Q2 | 384.53 Million CNY | 16.29% |
| 2022 Q4 | 498.88 Million CNY | 2.32% |
| 2022 Q3 | 487.58 Million CNY | 26.8% |
| 2022 FY | 498.88 Million CNY | 42.65% |
| 2021 Q2 | 375.79 Million CNY | 10.5% |
| 2021 Q1 | 340.07 Million CNY | -21.54% |
| 2021 Q3 | 307.43 Million CNY | -18.19% |
| 2021 Q4 | 349.73 Million CNY | 13.76% |
| 2021 FY | 349.73 Million CNY | -19.31% |
| 2020 Q4 | 433.43 Million CNY | 14.46% |
| 2020 Q3 | 378.69 Million CNY | 0.72% |
| 2020 Q2 | 376 Million CNY | 7.8% |
| 2020 Q1 | 348.8 Million CNY | -16.22% |
| 2020 FY | 433.43 Million CNY | 4.11% |
| 2019 Q2 | 385.53 Million CNY | 0.0% |
| 2019 FY | 416.34 Million CNY | -2.49% |
| 2019 Q4 | 416.34 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 426.97 Million CNY | 0.03% |
| 2017 FY | 426.86 Million CNY | 25.47% |
| 2016 FY | 340.21 Million CNY | 245.66% |
| 2015 FY | 98.42 Million CNY | 15.03% |
| 2014 FY | 85.56 Million CNY | -70.49% |
| 2013 Q1 | 394.66 Million CNY | -5.07% |
| 2013 Q3 | 392.89 Million CNY | 3.16% |
| 2013 FY | 289.98 Million CNY | -30.25% |
| 2013 Q2 | 380.87 Million CNY | -3.5% |
| 2012 Q3 | 315.51 Million CNY | 0.0% |
| 2012 Q1 | 309.33 Million CNY | 1.4% |
| 2012 Q4 | 415.74 Million CNY | 31.77% |
| 2012 FY | 415.74 Million CNY | 36.28% |
| 2011 Q2 | 275.87 Million CNY | 8.7% |
| 2011 FY | 305.06 Million CNY | 308.33% |
| 2011 Q4 | 305.06 Million CNY | 3.9% |
| 2011 Q3 | 293.61 Million CNY | 6.43% |
| 2011 Q1 | 253.78 Million CNY | 239.69% |
| 2010 Q4 | 74.71 Million CNY | -7.03% |
| 2010 FY | 74.71 Million CNY | -2.18% |
| 2010 Q3 | 80.35 Million CNY | 0.0% |
| 2009 FY | 76.37 Million CNY | -19.42% |
| 2008 FY | 94.78 Million CNY | 27.92% |
| 2007 FY | 74.09 Million CNY | 2.79% |
| 2006 FY | 72.09 Million CNY | 0.0% |